Stallergenes' Immunotherapy Tablet Containing Recombinant Birch Pollen Allergen
Filed in archive Allergy Medications , Allergy: Research and Development , Hay Fever on September 25, 2009
© MiikaSStallergenes has announced positive results on a new phase IIb/III clinical trial on the efficacy of a sublingual immunotherapy tablet containing the recombinant allergen of this birch pollen, rBet v 1 in allergic rhinitis caused by this pollen. This study is the first ever to use a recombinant allergen as an active substance and possibly also the first in the world to use a recombinant protein in dry form.
The 3 treated groups demonstrated a statistically significant reduction in AASS in comparison with placebo (0.002
© MiikaS
Tags: immunotherapy pollen+allergy hay+fever hayfever birch+allergies genetics allergy birch+pollen
Vote for Stallergenes' Immunotherapy Tablet Containing Recombinant Birch Pollen Allergen :
|
Rating: 7.50 out of 2 vote(s) cast.
|
Response from:
Stephen
(09/22/09 1:05pm)
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Allergy Basics
Allergy Blogs
Allergy Medications
Allergy Support Groups
Allergy to Drugs
Allergy: Diagnostics and Treatment
Allergy: Research and Development
Asthma
Best of
Did you know
Dust Mite Allergies
Food Allergies
Gadgets and Tools Against Allergies
Hay Fever
Information About
Insect Allergies
Latex/Rubber Allergies
Living with Allergies
Metal Allergies
Misc
Take ALLERGIES > Out of Your / Your Child's Future.
the Time is NOW to > Drop Your Allergies.
Best Health = Wealth Regards,
Stephen